Spatial metabolomics data indicated significant alterations in arginine metabolic pathways within the colon tumor model due to GDNPs (Fig. 2H), potentially linked to the reduction of ARG1 releasing during GDNPs-induced macrophage reprogramming. This evidence concerns the gene ARG1 and colonic neoplasm.